Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group Limited has announced that its CEO Shawn Patrick O’Brien will present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 10, 2024. The presentation will be accessible via webcast and is expected to attract investors interested in the company’s focus on innovative dermatology and women’s health pharmaceuticals, as well as their global contract development and manufacturing services.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
